DM
Therapeutic Areas
SpeeDx Pipeline
| Drug | Indication | Phase |
|---|---|---|
| RespiV Plex Plus | Respiratory viruses (14‑target panel) | Commercial |
| Plex PCR SARS‑CoV‑2 | COVID‑19 detection | Commercial |
| Resistance Plus GC | Neisseria gonorrhoeae detection + ciprofloxacin susceptibility | Commercial |
| Resistance Plus MG | Mycoplasma genitalium detection + macrolide resistance | Commercial |
| Plex PCR HSV‑VZV‑TP | Herpes simplex, varicella‑zoster, syphilis detection | Commercial |
| Enteric Plex Parasite | Gastroenteritis parasite panel | Commercial |
| Enteric Plex Bacteria I | Bacterial gastroenteritis panel | Commercial |